Larimar Therapeutics (LRMR) Change in Acquisitions & Divestments (2015 - 2025)

Larimar Therapeutics (LRMR) has reported Change in Acquisitions & Divestments for 11 consecutive years, with $34.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 41.38% year-over-year to $34.0 million; the trailing twelve-month figure through Dec 2025 stood at $184.0 million (up 28.67% YoY), and the FY2025 full-year result was $184.0 million, up 28.67% from the prior year.
• Change in Acquisitions & Divestments retreated to $34.0 million in Q4 2025 per LRMR's latest filing, from $36.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $92.2 million in Q1 2023 and bottomed at $9000.0 in Q2 2023.
• Historically, Change in Acquisitions & Divestments has averaged $32.1 million across 5 years, with a median of $26.1 million in 2022.
• The widest YoY moves for Change in Acquisitions & Divestments: up 205455.56% in 2024, down 82.11% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $6.5 million in 2021, then soared by 203.85% to $19.8 million in 2022, then surged by 64.56% to $32.5 million in 2023, then surged by 78.46% to $58.0 million in 2024, then plunged by 41.38% to $34.0 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $34.0 million, $36.5 million, and $46.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.